Tags

Type your tag names separated by a space and hit enter

COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021.
MMWR Morb Mortal Wkly Rep. 2021 May 28; 70(21):792-793.MM

Abstract

COVID-19 vaccines are a critical tool for controlling the ongoing global pandemic. The Food and Drug Administration (FDA) has issued Emergency Use Authorizations for three COVID-19 vaccines for use in the United States.* In large, randomized-controlled trials, each vaccine was found to be safe and efficacious in preventing symptomatic, laboratory-confirmed COVID-19 (1-3). Despite the high level of vaccine efficacy, a small percentage of fully vaccinated persons (i.e. received all recommended doses of an FDA-authorized COVID-19 vaccine) will develop symptomatic or asymptomatic infections with SARS-CoV-2, the virus that causes COVID-19 (2-8).

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34043615

Citation

CDC COVID-19 Vaccine Breakthrough Case Investigations Team. "COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021." MMWR. Morbidity and Mortality Weekly Report, vol. 70, no. 21, 2021, pp. 792-793.
CDC COVID-19 Vaccine Breakthrough Case Investigations Team. COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(21):792-793.
CDC COVID-19 Vaccine Breakthrough Case Investigations Team. (2021). COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021. MMWR. Morbidity and Mortality Weekly Report, 70(21), 792-793. https://doi.org/10.15585/mmwr.mm7021e3
CDC COVID-19 Vaccine Breakthrough Case Investigations Team. COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021. MMWR Morb Mortal Wkly Rep. 2021 May 28;70(21):792-793. PubMed PMID: 34043615.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021. A1 - ,, Y1 - 2021/05/28/ PY - 2021/5/27/entrez PY - 2021/5/28/pubmed PY - 2021/5/29/medline SP - 792 EP - 793 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 70 IS - 21 N2 - COVID-19 vaccines are a critical tool for controlling the ongoing global pandemic. The Food and Drug Administration (FDA) has issued Emergency Use Authorizations for three COVID-19 vaccines for use in the United States.* In large, randomized-controlled trials, each vaccine was found to be safe and efficacious in preventing symptomatic, laboratory-confirmed COVID-19 (1-3). Despite the high level of vaccine efficacy, a small percentage of fully vaccinated persons (i.e. received all recommended doses of an FDA-authorized COVID-19 vaccine) will develop symptomatic or asymptomatic infections with SARS-CoV-2, the virus that causes COVID-19 (2-8). SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/34043615/COVID-19_Vaccine_Breakthrough_Infections_Reported_to_CDC_-_United_States,_January_1-April_30,_2021. L2 - https://doi.org/10.15585/mmwr.mm7021e3 DB - PRIME DP - Unbound Medicine ER -